GCG and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: Teduglutide (Gattex, Revestive) is the first and the only GLP-2 analogue that has been approved for medical treatment of short bowel syndrome (SBS).